This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Death rate “spikes at the weekend”
Bayer and Onyx announce Phase III trial results
Call for greater clinical consensus on breakthrough cancer pain
Nivestim, a new biosimilar filgrastim, is approved in Europe
Alzheimer’s database to be created
Study looks at OAP chronic pain
Cancer drug “prevents sight loss”
Evolva shareholders approve all Board proposals in AGM
Stress linked to healing speeds
Use of cancer drug rejected by NICE
UCB strengthens strategic alliance with WILEX
Unit dose drug distribution in Europe
« Previous
1
…
61
62
63
64
65
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: